ANNA BUTEAU: Open Payments
NPI 1780114215 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,090 in 46 payments from 13 companies in 2025. Trend: 2023 $1,175 · 2024 $1,190 · 2025 $1,090
Food & beverage: $1,090
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $360 |
| Shockwave Medical, Inc | 1 | $147 |
| Abbott Laboratories | 7 | $135 |
| Eisai Inc. | 1 | $110 |
| GlaxoSmithKline, LLC. | 4 | $83 |
| Lilly USA, LLC | 5 | $82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| Astellas Pharma US Inc | 1 | $31 |
| Amgen Inc. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $25 |
Products named: Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, Ozempic, Rybelsus, Leqembi, MOUNJARO, FREESTYLE LIBRE 3, PROCLAIM, Wegovy.
Industry payments across TX — which companies pay providers there.
